Sanchez–Alcudia et al. reported the genotype and phenotype association of 36 patients with CHM variants and demonstrated that patients carrying complete deletions of CHM had an earlier onset of night blindness (9.6 ± 4.7 years old) compared with all patients (18 years old)34. Here, CHM is linked to night blindness.